(HealthDay)—Office-based visits for behavioral and psychiatric conditions decreased in association with the COVID-19 pandemic, although increases in telemedicine visits offset these decreases, according to a research letter published online Nov. 17 in the Annals of Internal Medicine.
Omar Mansour, from Johns Hopkins University in Baltimore, and colleagues characterized quarterly telemedicine and office-based visits from the first quarter of 2018 (2018Q1) through the second quarter of 2020 (2020Q2) and focused on care for six of the most prevalent behavioral and psychiatric conditions.
The researchers found that for the six conditions, total visits decreased from an average of 15.9 million during the first quarter of 2018 and 2019 to 13.0 million in 2020Q1 (18 percent decrease) and then increased to 15.8 million in 2020Q2. There was a decrease noted in office-based visits, from an average quarterly volume of 15.5 million before 2020 to 11.9 and 5.3 million in 2020Q1 and 2020Q2, respectively. Telemedicine visits accounted for fewer than 3 percent of visits before 2020 and increased to 9 and 66 percent of visits during 2020Q1 and 2020Q2 (1.1 and 10.5 million, respectively). Even after the shift to telemedicine starting in 2020, most visits were subsequent visits rather than new visits.
“Given concerns about the potential deleterious effects of the pandemic on the behavioral and psychiatric needs of vulnerable populations as well as the implementation of policies to mitigate such harms, the increases in telemedicine visits are noteworthy,” the authors write.
Two authors disclosed financial ties to the health care and life science industries.
Primary care visits dropped in early months of the pandemic
Copyright © 2020 HealthDay. All rights reserved.
Behavioral, psych condition care shifted to telemedicine during COVID-19 (2020, November 20)
retrieved 20 November 2020
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no
part may be reproduced without the written permission. The content is provided for information purposes only.
- COVID case rates hit new high for England, study finds - April 7, 2022
- Govt’s focus on affordable healthcare ensured significant savings for poor, middle class: PM Modi - April 7, 2022
- SRL Diagnostics and Skye Air Mobility collaborate to transport pathology samples using drone logistics - April 6, 2022
- Healthineers sets up new production line of CT scanners in Bengaluru under PLI scheme - April 6, 2022
- Lupin inks licensing pact with Alvion to market drugs in Southeast Asia - April 6, 2022
- Yoga Mahotsav: Ayush Ministry to organise event to demonstrate common yoga on World Health Day - April 6, 2022
- LordsMed forays into the medtech space with launch of health ATMs ‘Lords Sehat’ - April 5, 2022
- ‘Friendly viruses’ can be the next big thing in the history of medical research and more - April 5, 2022
- No setback to Bharat Biotech even as WHO suspends Covaxin UN supply: Sources - April 4, 2022
- Govt panel recommends Serum’s Covovax dose for kids aged 12 and above - April 4, 2022